ClinicalFDA Approved
Vasopressin
Also known as: ADH · Arginine vasopressin · AVP
The body's survival nonapeptide — used as a final-line hemodynamic rescue agent in septic shock and vasodilatory collapse.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
Half-Life
~18 minutes
Typical Dose
0.01–0.04 units/min (IV infusion)
Administration
Intravenous
Mechanism of Action
Activates V1a receptors on vascular smooth muscle for vasoconstriction and V2 receptors in kidneys for water retention.
Key Research Areas
clinicalFDA approvedshockICUhemodynamic
Frequently Asked Questions
What is Vasopressin?▾
The body's survival nonapeptide — used as a final-line hemodynamic rescue agent in septic shock and vasodilatory collapse.
How does Vasopressin work?▾
Activates V1a receptors on vascular smooth muscle for vasoconstriction and V2 receptors in kidneys for water retention.
What is the recommended dosage for Vasopressin?▾
The typical research dosage is 0.01–0.04 units/min (IV infusion), administered via Intravenous. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Vasopressin?▾
The half-life of Vasopressin is approximately ~18 minutes. This affects dosing frequency and timing in research protocols.
Is Vasopressin FDA approved?▾
Yes, Vasopressin is FDA approved for specific medical indications. Consult your physician for proper medical guidance.
Research Disclaimer
The information provided about Vasopressin is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.